Brooks Laboratories approves FY26 financials at 24th AGM

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Brooks Laboratories held its 24th AGM on September 3, 2026, via video conferencing
  • Shareholders approved FY26 standalone and consolidated financial statements
  • Jitendra Pratap Singh was reappointed as a director retiring by rotation
  • Remuneration for President Strategy Atul Ranchal and President Trading Rajesh Mahajan was approved
powered bylight_fuzz_icon
49982112

*this image is generated using AI for illustrative purposes only.

Brooks Laboratories concluded its 24th Annual General Meeting on September 3, 2026. The meeting, held via video conferencing, saw shareholders approve the company’s standalone and consolidated financial statements for the fiscal year ended March 31, 2026.

Dr. Usha Singh, Non-Executive Independent Director, chaired the proceedings. A quorum of 319 members was present to transact business.

Key Resolutions Passed

The shareholders approved seven ordinary resolutions during the meeting. The key decisions included:

  • Adoption of the annual audited standalone and consolidated financial statements for FY26.
  • Reappointment of Mr. Jitendra Pratap Singh as a director, replacing those retiring by rotation.
  • Ratification of cost auditor remuneration.
  • Approval of related party transactions.
  • Remuneration approval for Mr. Atul Ranchal, President – Strategy, and Mr. Rajesh Mahajan, President – Trading, under Section 188(1)(f) of the Companies Act, 2013.

Management Presence

The following directors and key managerial personnel attended the meeting via video conference:

  • Dr. Usha Singh, Non-Executive Independent Director
  • Mr. Bhushan Singh Rana, Wholetime Director
  • Mr. Manav Mahajan, Non-Executive Independent Director
  • Mr. Lalit Mahajan, Non-Executive Independent Director
  • Mr. Jitendra Pratap Singh, Wholetime Director
  • Dr. Durga Shankar Maity, Wholetime Director
  • Mr. Prashant Rathi, Chief Executive Officer & Chief Financial Officer
  • Ms. Krutika Rane, Company Secretary

Statutory Auditor Ms. Malavika Lokeshwar and Secretarial Auditors Mr. P.D. Sharma and Mr. G. S Sarin were also present. Mr. G. S Sarin served as the scrutinizer for the e-voting process.

Voting Process

The company provided remote e-voting facilities in compliance with SEBI Listing Regulations. The e-voting facility remained available for 15 minutes after the meeting’s conclusion. Detailed voting results are to be submitted to BSE Limited and National Stock Exchange of India Ltd within two working days.

Historical Stock Returns for Brooks Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-1.46%+2.07%+5.20%+2.43%-52.56%-47.34%

How will the approved remuneration structure for key strategy and trading executives impact Brooks Laboratories' operational costs and profit margins in FY27?

What strategic initiatives is Mr. Jitendra Pratap Singh expected to prioritize following his reappointment as a director?

How might the approved related party transactions influence the company's supply chain resilience or cost efficiency in the coming fiscal year?

Brooks Laboratories amends AGM resolution for ₹48.15 crore BSL guarantee

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Brooks Laboratories issued an addendum on August 22, 2026, for its September 3 AGM
  • Resolution 4 amended to ratify ₹48.15 crore guarantee for joint venture BSL
  • Proposed FY27 related-party transaction limits total ₹35 crore plus guarantee
  • Aggregate exposure represents 96.99% of prior year consolidated turnover
powered bylight_fuzz_icon
47661444

*this image is generated using AI for illustrative purposes only.

Brooks Laboratories Limited issued an addendum on August 22, 2026, to the notice of its 24th Annual General Meeting (AGM), scheduled for September 3, 2026. The update amends Resolution No. 4 to align with corporate guarantee arrangements involving its jointly controlled entity, Brooks Steriscience Limited (BSL). The company published the addendum in Financial Express and Jansatta on August 22, 2026.

The original AGM notice, dated July 31, 2026, and dispatched on August 12, 2026, remains valid except for the modifications detailed in the addendum. Shareholders must read the addendum collectively with the initial notice and the Annual Report for FY25-26.

Related Party Transaction Details

The amendment seeks shareholder approval to ratify a corporate guarantee of ₹48.15 crore provided in favor of BSL during March 2026. This guarantee was approved by the Audit Committee in its meeting held on February 6, 2026. The company proposes an overall corporate guarantee limit of up to ₹48.15 crore for BSL. Any further guarantees will require enhancement of this limit and applicable approvals.

In addition to the guarantee, the company proposes to continue operational transactions with BSL during FY26-27:

  • Purchase of goods and commissions: up to ₹15 crore
  • Sale of goods and commissions: up to ₹15 crore
  • Job work services and shared services: up to ₹5 crore

The aggregate value of these transactions, including the corporate guarantee limit, represents approximately 96.99% of the company’s annual consolidated turnover for the immediately preceding financial year. Atul Ranchal is identified as a related party director interested in these transactions.

Other AGM Resolutions

The AGM agenda includes several other key resolutions:

  • Cost Auditor Ratification: Ratification of remuneration payable to M/s. Balwinder & Associates for FY26-27 cost audit, amounting to ₹60,000 plus taxes.
  • Director Reappointment: Reappointment of Mr. Jitendrapratap Rambahadur Singh, who retires by rotation.
  • Executive Remuneration: Approval of remuneration for Mr. Atul Ranchal, President – Strategy, at a maximum of ₹15 lakh per month, effective September 1, 2026. Additionally, remuneration for Mr. Rajesh Mahajan, President – Trading, at a maximum of ₹8 lakh per month, effective July 17, 2026.

Key Dates and Logistics

The Register of Members will remain closed from August 27, 2026, through September 3, 2026. Remote e-voting opens on August 31, 2026, at 9:00 am and closes on September 2, 2026, at 5:00 pm. The AGM will be conducted exclusively via Video Conferencing or Other Audio-Visual Means (VC/OAVM), starting at 9:00 am IST.

Event Date/Time Mode
AGM Date September 3, 2026 VC/OAVM
Start Time 9:00 am IST Virtual
Book Closure Start August 27, 2026 N/A
Book Closure End September 3, 2026 N/A
E-Voting Cut-Off August 27, 2026 N/A
Remote E-Voting Start August 31, 2026, 9:00 am IST Online
Remote E-Voting End September 2, 2026, 5:00 pm IST Online

Shareholders are advised to ensure their email addresses are registered with their Depository Participants or the Registrar and Share Transfer Agent, MUFG Intime India Private Limited, to receive communications electronically. Attendance via VC/OAVM counts toward the quorum requirement under Section 103 of the Companies Act, 2013.

Historical Stock Returns for Brooks Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-1.46%+2.07%+5.20%+2.43%-52.56%-47.34%

How might the high concentration of related-party transactions, representing nearly 97% of turnover, impact Brooks Laboratories' operational independence and risk profile in FY26-27?

What are the specific strategic growth drivers for Brooks Steriscience Limited that justify the ₹48.15 crore corporate guarantee and continued financial support from the parent company?

Will the approved remuneration increases for President Atul Ranchal and President Rajesh Mahajan correlate with specific performance targets or expansion goals for the Strategy and Trading divisions?

More News on Brooks Laboratories

1 Year Returns:-52.56%